The OPTION Clinical Trial

The OPTION Clinical Trial

The OPTION Clinical Trial

The purpose of the OPTION trial is to determine if left atrial appendage closure with the WATCHMAN FLXTM Implant is a reasonable alternative to blood thinners for stroke protection following AFib ablation.​​

By joining this study, you may have the opportunity to receive the WATCHMAN FLX Implant.* If you agree to be in this study, you will be expected to visit your study doctor for required screenings. You also may be required to attend follow-up visits about once a year for three years.​

See the Implant Procedure

NOTE: The OPTION Trial uses the WATCHMAN FLXTM Left Atrial Appendage Closure Device, which is an investigational device and not available for sale in the U.S. WATCHMAN FLXTM  is CE Marked.

Is OPTION Right For Me?

You may be a candidate for the OPTION clinical trial if you can answer yes to the following questions:

  I have been diagnosed with AFib not caused by a heart valve problem.​
✓   I have had or have been recommended for an AFib ablation.​
   I am interested in an alternative to the long-term use of blood thinners for stroke risk

Learn More About OPTION

If you answered yes to all of the above, consider talking to your heart doctor or locating your nearest OPTION implanting center.
NOTE: The OPTION Trial uses the WATCHMAN FLXTM Left Atrial Appendage Closure Device, which is an investigational device and not available for sale in the U.S. WATCHMAN FLXTM  is CE Marked.
Top